FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Extends Review of Stealth Bio NDA

[ Price : $8.95]

FDA extends its review of a Stealth BioTherapeutics NDA for elamipretide, a first-in-class mitochondria-targeted therapeutic for t...

Orphan Status for Zai Labs Lung Cancer Drug

[ Price : $8.95]

FDA grants Zai Lab an orphan drug designation to ZL-1310, an antibody-drug conjugate for treating small cell lung cancer.

Continue Strong Compliance, Quality Programs: Attorneys

[ Price : $8.95]

Three Ropes & Gray attorneys review major FDA-related enforcement cases in 2024 and say it is impossible to predict with certainty...

Implement Digital Technologies Carefully: GE HealthCare

[ Price : $8.95]

Two medical device stakeholders suggest ways for FDA to regulate generative AI and foundation model-enabled medical devices.

FDA Will Review Biogen Spinraza sNDA

[ Price : $8.95]

FDA will review a Biogen sNDA for a Spinraza higher dose regimen.

FDA Removes Diversity Docs From Web Site

[ Price : $8.95]

FDA removes information and documents regarding several diversity-related initiatives and policies, presumably in response to a Tr...

Former FDA Womens Health Head Wood Dies

[ Price : $8.95]

Former FDA associate commissioner for womens health Susan Wood passes away at her home in London after battling glioblastoma (brai...

Durbin, Grassley Reintroduce Drug Ad Price Bill

[ Price : $8.95]

A bipartisan group of senators reintroduce legislation to mandate the inclusion of drug prices in direct-to-consumer ads.

New Copaxone Boxed Warning

[ Price : $8.95]

FDA says it is adding a Boxed Warning for anaphylaxis to the labeling for Tevas multiple sclerosis drug Copaxone and its Sandoz ge...

CBER Approved 67 Products in 2024: Report

[ Price : $8.95]

CBER director Peter Marks report for 2024 discusses Center approval of 67 products it says integrated advances in science and tech...